These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24676538)

  • 1. Downregulation of LKB1 suppresses Stat3 activity to promote the proliferation of esophageal carcinoma cells.
    Wang YQ; Dai WM; Chu XY; Yang B; Zhao M; Sun Y
    Mol Med Rep; 2014 Jun; 9(6):2400-4. PubMed ID: 24676538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
    Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
    Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma.
    Liu K; Luo Y; Tian H; Yu KZ; He JX; Shen WY
    Tumour Biol; 2014 Feb; 35(2):995-1002. PubMed ID: 24022664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy.
    Hu MT; Wang JH; Yu Y; Liu C; Li B; Cheng QB; Jiang XQ
    Int J Oncol; 2018 Sep; 53(3):1215-1226. PubMed ID: 30015925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1.
    Wang Z; Zhu S; Shen M; Liu J; Wang M; Li C; Wang Y; Deng A; Mei Q
    Carcinogenesis; 2013 Mar; 34(3):678-88. PubMed ID: 23172665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo.
    Pan Y; Zhang L; Zhang X; Liu R
    Oncol Rep; 2015 Feb; 33(2):774-82. PubMed ID: 25420630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
    Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
    Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion.
    Gu Y; Lin S; Li JL; Nakagawa H; Chen Z; Jin B; Tian L; Ucar DA; Shen H; Lu J; Hochwald SN; Kaye FJ; Wu L
    Oncogene; 2012 Jan; 31(4):469-79. PubMed ID: 21706049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression.
    Kang M; Li Y; Liu W; Wang R; Tang A; Hao H; Liu Z; Ou H
    Int J Mol Med; 2013 Jul; 32(1):51-8. PubMed ID: 23677061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.
    Timme S; Ihde S; Fichter CD; Waehle V; Bogatyreva L; Atanasov K; Kohler I; Schöpflin A; Geddert H; Faller G; Klimstra D; Tang L; Reinheckel T; Hauschke D; Busch H; Boerries M; Werner M; Lassmann S
    Oncogene; 2014 Jun; 33(25):3256-66. PubMed ID: 23912451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
    Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH
    Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation.
    Whitsett TG; Mittal SK; Eschbacher JM; Carson VM; Smith MA; Bremner RM; Inge LJ
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1891-1899. PubMed ID: 29370903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous activation of LKB1/AMPK signaling induces G₁ arrest in cells with endogenous LKB1 expression.
    Liang X; Wang P; Gao Q; Tao X
    Mol Med Rep; 2014 Mar; 9(3):1019-24. PubMed ID: 24469340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LKB1 catalytically deficient mutants enhance cyclin D1 expression.
    Scott KD; Nath-Sain S; Agnew MD; Marignani PA
    Cancer Res; 2007 Jun; 67(12):5622-7. PubMed ID: 17575127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lung cancer cell invasion by LKB1 is due to the downregulation of tissue factor and vascular endothelial growth factor, partly dependent on SP1.
    Liang X; Li ZL; Jiang LL; Guo QQ; Liu MJ; Nan KJ
    Int J Oncol; 2014 Jun; 44(6):1989-97. PubMed ID: 24647869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
    Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
    Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of transfection of LKB1 on biological behavior of human lung adenocarcinoma cells].
    Liang X; Nan KJ; Li CL; Yao Y; Tian T; Wang SH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1140-2. PubMed ID: 19068194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic correlations of liver kinase B1, E-cadherin, and N-cadherin expression in non-small cell lung cancer.
    Liu S; Miao Y; Fan C; Liu Y; Yu J; Zhang Y; Dai S; Wang E
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):334-40. PubMed ID: 23235348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.